INVO Bioscience | S-3: Registration statement for specified transactions by certain issuers
INVO Bioscience | 8-K: INVO Reports Record First Quarter 2024 Financial Results 353% Revenue Growth with improvement in Adjusted EBITDA
INVO Bioscience | 8-K: Current report
INVO Bioscience | 8-K: Current report
INVO Bioscience | 8-K: Current report
INVO Bioscience | 8-K: INVO Reports Fourth Quarter and Full Year 2023 Financial Results
INVO Bioscience | 8-K: Current report
INVO Bioscience | 8-K/A: Current report (Amendment)
INVO Bioscience | NT 10-K: Others
INVO Bioscience | 8-K: Current report
INVO Bioscience | 8-K: Current report
INVO Bioscience | 8-K: Current report
INVO Bioscience | 8-K/A: Current report (Amendment)
INVO Bioscience | 8-K: Current report
INVO Bioscience | 8-K: Current report
INVO Bioscience | 8-K: Current report
INVO Bioscience | 8-K: Current report
INVO Bioscience | DEFA14A: Others
INVO Bioscience | 8-K: Current report
INVO Bioscience | 8-K: Current report
No Data